Abstract
In spontaneously hypertensive rats opioid receptor blockade by naloxone reversed the antihypertensive effect of clonidine (Farsang and Kunos 1979, Farsang et al. 1980; Kunos et al. 1981; Baum and Becker 1982; Ramirez-Gonzales et al. 1983). A similar effect of naloxone was reported in normotensive rats by Bennet et al. (1982), whereas Farsang et al. (1980) found that naloxone was without effect. In man naloxone was without effect on the clonidine-induced fall in blood pressure in normotensive individuals (Watkins et al. 1980). In hypertensive man some investigators found that naloxone reduced the fall in blood pressure induced by clonidine (Farsang et al. 1982, 1984a, c), but other investigators were unable to confirm these results (Rogers and Cubeddu 1983; Pedrinelli et al. 1983; Mathias et al. 1985; Levin et al. 1986).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baum T, Becker FT (1982) Alpha-adrenergic and 5-hydroxytryptaminergic receptor stimulants as new antihypertensive drugs, with observations on involvement of opiate receptors. Clin Exp Hypertens [A] 4 (1-2): 235 - 248
Bennett DA, DeFeo JJ, Elko EE, Lai H (1982) Naloxone-induced reversal of Clonidine, but not hydralazine, hypotension. Drug Dev Res 2: 175 - 179
Bramnert M, Hökfelt B (1983) Failure of naloxone to reduce the Clonidine induced reduction of blood pressure and plasma noradrenaline in patients with essential hypertension. Acta Physiol Scand 118: 379 - 383
Cohen EL, Grim CE, Conn JW, Blough WM Jr, Guyer RB, Kem DC, Lucas CP (1971) Accurate and rapid measurement of plasma renin activity by radioimmunoassay. J Lab Clin Med 77: 1025 - 1038
Farsang C, Kunos G (1979) Naloxone reverses the antihypertensive effect of Clonidine. Br J Pharmacol 67: 161 - 164
Farsang C, Ramirez-Gonzalez MD, Mucci L, Kunos G (1980) Possible role of an endogenous opiate in the cardiovascular effect of central alpha adrenoreceptor stimulation in spontaneously hypertensive rats. J Pharmacol Exp Ther 214: 203 - 208
Farsang C, Kapocsi J, Juhasz I, Kunos G (1982) Possible involvement of an endogenous opioid in the antihypertensive effect of Clonidine in patients with essential hypertension. Circulation 66: 1268 - 1282
Farsang C, Vajda L, Kapocsi J, Malisak Z, Alföldi S, Varga K, Juhasz I, Kunos G (1983) Diurnal rhythm of beta-endorphin in normotensive and hypertensive patients: the effect of Clonidine. J Clin Endorinol Metab 56: 865 - 867
Farsang C, Varga K, Vajda L, Alföldi S, Kapocsi J (1984a) Effects of Clonidine and guanfacine in essential hypertension. Clin Pharmacol Ther 36: 588 - 594
Farsang C, Varga K, Vajda L, Kapocsi J, Balas-Eltes A, Kunos G (1984b) Beta-endorphin contributes to the antihypertensive effect of Clonidine in a subset of patients with essential hypertension. Neuropeptides 4: 293 - 302
Farsang C, Kapocsi J, Vajda L, Varga K, Malisak Z, Fekete M, Kunos G (1984c) Reversal by naloxone of the antihypertensive action of Clonidine: involvement of the symphathetic nervous system. Circulation 69: 461 - 467
Farsang C, Kapocsi J, Varga K, Vajda L, Balas-Eltes A, Kunos G (1985) Beta-endorphin and essential hypertension: importance of the clonidine-naloxone interaction. Acta Physiol Hung 65: 217 - 226
Goodfrey K (1985) Statistics in practice: comparing the means of levels of several groups. N Engl J Med 313: 1450 - 1456
Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349 - 1355
Kunos B, Farsang CA, Ramirez-Gonzales MD (1981) Beta-endorphin: possible involvement in the antihypertensive effect of central alpha-receptor activation. Science 211: 82 - 84
Levin ER, Sharp B, Weber MA, Drayer JIM (1986) Endogenous opioid peptides: do they mediate the acute antihypertensive action of Clonidine in humans? Horm Res 23: 193 - 199
Mathias CJ, da Costa DF, Cleary JC, Peart S (1985) Naloxone does not affect the cardiovascular, sedative or neurohormonal effects of Clonidine in normal and hypertensive man. J Hypertension 3: s77 - s79
Ogihara T, Inuma K, Nishi K, Arakawa Y, Takagi A, Kurata K, Miyai K, Kumahara Y (1977) A non- chromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocrinol Metab 45: 726 - 731
Pedrinelli R, Bernini G, Vivaldi MS, Salvetti A (1983) Interaction between central alpha-adrenergic stimulation and endogenous opioids in hypertensive man. J Hypertension 1: 243 - 245
Peuler JD, Johnson G A (1977) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sei 21: 625 - 636
Ramirez-Gonzales MD, Tchakarov L, Garcia RM, Kunos G (1983) Beta-endorphin acting on the brainstem is involved in the antihypertensive action of Clonidine and alpha-methyldopa in rats. Circ Res 53: 150 - 157
Rogers JF, Cubeddu LX (1983) Naloxone does not antagonize the antihypertensive effect of Clonidine in essential hypertension. Clin Pharmacol Ther 34: 68 - 73
Watkins J, Fitzgerald G, Zamboulis C, Brown MJ, Dollery CT (1980) Absence of opiate and histamine H2 receptor-mediated effects of Clonidine. Clin Pharmacol Ther 28: 605 - 610
Yasunari K, Kanayama Y, Kohno M, Murakawa K, Kawarabayashi T, Takeda T, Kotsugai N, Sato K (1985) Central alpha-activation by Clonidine reduces plasma level of beta-endorphin in patients with essential hypertension. Life Sci 37: 1461 - 1467
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bramnert, M., Hökfelt, B. (1988). Effect of Low Dosage of Naloxone on Clonidine- Induced Changes in Blood Pressure, Catecholamines, Renin, and Aldosterone in Essential Hypertension. In: Stumpe, K.O., Kraft, K., Faden, A.I. (eds) Opioid Peptides and Blood Pressure Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73429-8_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-73429-8_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18935-0
Online ISBN: 978-3-642-73429-8
eBook Packages: Springer Book Archive